Jo T - Search Results

1

Live attenuated VZV vaccination induces antitumor immunity in ATLL patients.

Jo T, Kubota-Koketsu R, Kaneko Y, Sakai T, Noguchi K, Irie S, Matsuo M, Taguchi J, Abe K, Shigematsu K. Jo T, et al. Cancer Immunol Immunother. 2023 Apr;72(4):929-944. doi: 10.1007/s00262-022-03301-6. Epub 2022 Oct 1. Cancer Immunol Immunother. 2023. PMID: 36181532 Free PMC article.

2

Two Cases of Cerebral Involvement in Malignant Lymphoma (CD20+) That Responded to Combination Therapy with Rituximab and Cladribine.

Jo T, Matsuo M, Horio K, Tomonaga M. Jo T, et al. Case Rep Oncol. 2012 May;5(2):260-6. doi: 10.1159/000339406. Epub 2012 May 24. Case Rep Oncol. 2012. PMID: 22712014 Free PMC article.

3

Extensive and destructive invasion of adult T-cell leukemia/lymphoma cells into systemic muscular tissues.

Jo T, Shigematsu K. Jo T, et al. Blood. 2014 Sep 4;124(10):1690. doi: 10.1182/blood-2014-03-561001. Blood. 2014. PMID: 25328961 Free PMC article. No abstract available.

4

Impact of Nagasaki atomic bomb exposure on myelodysplastic syndrome patients who are treated with azacitidine.

Jo T, Horio K, Shigematsu K. Jo T, et al. Anticancer Res. 2015 May;35(5):2929-33. Anticancer Res. 2015. PMID: 25964578

5

More on Sweet's syndrome in patients with MDS and MEFV mutations.

Jo T, Sakamoto K, Shigematsu K. Jo T, et al. N Engl J Med. 2015 May 14;372(20):1971-2. doi: 10.1056/NEJMc1503146. N Engl J Med. 2015. PMID: 25970067 No abstract available.

6

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Matsuo M, Iwanaga M, Kondo H, Soda M, Jo T, Horio K, Takasaki Y, Kawaguchi Y, Tsushima H, Imaizumi Y, Imanishi D, Taguchi J, Sawayama Y, Hata T, Miyazaki Y. Matsuo M, et al. Among authors: jo t. Cancer Sci. 2016 Oct;107(10):1484-1491. doi: 10.1111/cas.13025. Epub 2016 Sep 2. Cancer Sci. 2016. PMID: 27487572 Free PMC article.

7

Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Horai M, Satoh S, Matsuo M, Iwanaga M, Horio K, Jo T, Takasaki Y, Kawaguchi Y, Tsushima H, Yoshida S, Taguchi M, Itonaga H, Sawayama Y, Taguchi J, Imaizumi Y, Hata T, Moriuchi Y, Haase D, Yoshiura KI, Miyazaki Y. Horai M, et al. Among authors: jo t. Br J Haematol. 2018 Feb;180(3):381-390. doi: 10.1111/bjh.15050. Epub 2017 Dec 19. Br J Haematol. 2018. PMID: 29265181 Free article.

8

Long-lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib.

Jo T, Noguchi K, Hayashi S, Irie S, Hayase R, Shioya H, Kaneko Y, Horio K, Taguchi J. Jo T, et al. Oncol Lett. 2018 Mar;15(3):2935-2938. doi: 10.3892/ol.2017.7720. Epub 2017 Dec 29. Oncol Lett. 2018. PMID: 29435021 Free PMC article.

9

Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma.

Jo T, Matsuzaka K, Shioya H, Tominaga H, Sakai T, Kaneko Y, Hayashi S, Matsuo M, Taguchi J, Abe K, Shigematsu K, Kubota-Koketsu R. Jo T, et al. Anticancer Res. 2020 Sep;40(9):5237-5243. doi: 10.21873/anticanres.14527. Anticancer Res. 2020. PMID: 32878812

10

Elevation of Memory Cytotoxic T Lymphocytes, Including Human T Lymphotropic Virus Type 1 Tax-Specific and Hepatitis Virus Type C-Specific Cytotoxic T Lymphocytes, in a Patient with Adult T-Cell Leukemia/Lymphoma and Hepatocellular Carcinoma.

Jo T, Kaneko Y, Oishi T, Matsuzaka K, Shioya H, Sakai T, Tomoinaga H, Hayashi S, Matsuo M, Taguchi J. Jo T, et al. Case Rep Oncol. 2020 Jul 8;13(2):802-806. doi: 10.1159/000508092. eCollection 2020 May-Aug. Case Rep Oncol. 2020. PMID: 32884522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

501 results

Search Page